Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
15.02
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Psychedelic Stock Gainers And Losers From April 7, 2023
↗
April 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 6, 2023
↗
April 06, 2023
Via
Benzinga
Compass Pathways, GH Research Among Top Psychedelic Movers Of Today
↗
April 05, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 4, 2023
↗
April 04, 2023
Via
Benzinga
"Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD
↗
April 04, 2023
The
Via
Talk Markets
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
April 03, 2023
Via
Benzinga
Largest Psychedelic Stocks -3.4% In March
↗
April 02, 2023
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 31, 2023
↗
March 31, 2023
Via
Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
↗
March 30, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 29, 2023
↗
March 29, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 28, 2023
↗
March 28, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 27, 2023
↗
March 27, 2023
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
↗
March 24, 2023
Via
Benzinga
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
↗
March 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
↗
March 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
↗
March 21, 2023
Via
Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
↗
March 21, 2023
This is the third article of a three-part series, you can find the first and
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
↗
March 20, 2023
Via
Benzinga
Cannabis Category Performance Comparisons: An Update
↗
March 19, 2023
Here is a summary of how each of the 5 categories in the cannabis sector has performed month-to-date, in descending order, and year-to-date. The picture isn't pretty.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 17, 2023
↗
March 17, 2023
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
↗
March 16, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
↗
March 15, 2023
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
↗
March 14, 2023
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
↗
March 13, 2023
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
↗
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
↗
March 13, 2023
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll...
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
March 10, 2023
Via
Benzinga
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
↗
March 10, 2023
Clinical-stage biopharma company Mind Medicine (MindMed), Inc. (NASDAQ: MNMD) shared its financial results for the full year ended Dec. 31, 2022. Numbers show solid stability:
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
↗
March 09, 2023
Via
Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
March 08, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today